Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Assets (2016 - 2025)

Historic Return on Assets for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to 0.22%.

  • China Pharma Holdings' Return on Assets rose 1300.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.3% for FY2024, which is 1200.0% down from last year.
  • Per China Pharma Holdings' latest filing, its Return on Assets stood at 0.22% for Q3 2025, which was up 1300.0% from 0.26% recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Return on Assets peaked at 0.15% during Q1 2021, and registered a low of 0.34% during Q3 2024.
  • In the last 5 years, China Pharma Holdings' Return on Assets had a median value of 0.2% in 2023 and averaged 0.22%.
  • In the last 5 years, China Pharma Holdings' Return on Assets surged by 7900bps in 2021 and then crashed by -1400bps in 2024.
  • Quarter analysis of 5 years shows China Pharma Holdings' Return on Assets stood at 0.17% in 2021, then plummeted by -40bps to 0.23% in 2022, then grew by 17bps to 0.19% in 2023, then plummeted by -73bps to 0.33% in 2024, then skyrocketed by 35bps to 0.22% in 2025.
  • Its Return on Assets was 0.22% in Q3 2025, compared to 0.26% in Q2 2025 and 0.31% in Q1 2025.